Search This Blog

Tuesday, November 12, 2019

Sage Therapeutics EPS misses by $0.07, beats on revenue

Sage Therapeutics (NASDAQ:SAGE): Q3 GAAP EPS of -$3.48 misses by $0.07.
Revenue of $3.57M beats by $1.05M.
Shares -1% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)